Antifungal stewardshipの実践とカンジダ血症の予後に関与する要因

カンジダ血症は入院患者の主要な侵襲性真菌感染症であり,高い死亡率をもたらす.Antifungal stewardship(AFS)によりカンジダ血症の予後の改善や抗真菌薬の副作用,耐性化抑制などが期待される.カンジダ血症に対して行うべき事項はバンドルとして示され,遵守により予後改善の効果が期待される.AFSの実際としてACTIONsバンドルを用いたカンジダ血症のマネジメントを行い,カンジダ血症における予後に関与する要因の検討を行った.血液培養の陰性化後2週間の抗真菌薬投与は予後の改善の要因となった.一方,肝硬変を含む肝機能障害,低い予後栄養指数,高Acute Physiology and Ch...

Full description

Saved in:
Bibliographic Details
Published in日本医真菌学会雑誌 Vol. 63; no. 4; pp. 93 - 98
Main Authors 石川, かおり, 植田, 貴史, 一木, 薫, 竹末, 芳生, 山田, 久美子, 中嶋, 一彦
Format Journal Article
LanguageJapanese
Published 一般社団法人 日本医真菌学会 31.10.2022
Subjects
Online AccessGet full text
ISSN2434-5229
2434-5237
DOI10.11534/ishinkin.22.011

Cover

Abstract カンジダ血症は入院患者の主要な侵襲性真菌感染症であり,高い死亡率をもたらす.Antifungal stewardship(AFS)によりカンジダ血症の予後の改善や抗真菌薬の副作用,耐性化抑制などが期待される.カンジダ血症に対して行うべき事項はバンドルとして示され,遵守により予後改善の効果が期待される.AFSの実際としてACTIONsバンドルを用いたカンジダ血症のマネジメントを行い,カンジダ血症における予後に関与する要因の検討を行った.血液培養の陰性化後2週間の抗真菌薬投与は予後の改善の要因となった.一方,肝硬変を含む肝機能障害,低い予後栄養指数,高Acute Physiology and Chronic Health EvaluationⅡスコアは予後の不良の要因であった.適切な抗真菌薬の選択と用法用量,治療期間は予後の改善する重要な項目である.一方,高齢,腎機能障害,肝機能障害,ステロイドを含む免疫抑制薬の使用などの患者背景もカンジダ血症の発生や予後不良のリスクとなることが知られており,コントロールが困難であることも多い.患者の栄養指標やリンパ球数も予後の予測因子となり,栄養状態の改善はカンジダ血症の予後向上のために行うべき対策である.この総説ではAFS活動とリスク要因となる患者の疾患背景をおもに取り上げ概説する.
AbstractList カンジダ血症は入院患者の主要な侵襲性真菌感染症であり,高い死亡率をもたらす.Antifungal stewardship(AFS)によりカンジダ血症の予後の改善や抗真菌薬の副作用,耐性化抑制などが期待される.カンジダ血症に対して行うべき事項はバンドルとして示され,遵守により予後改善の効果が期待される.AFSの実際としてACTIONsバンドルを用いたカンジダ血症のマネジメントを行い,カンジダ血症における予後に関与する要因の検討を行った.血液培養の陰性化後2週間の抗真菌薬投与は予後の改善の要因となった.一方,肝硬変を含む肝機能障害,低い予後栄養指数,高Acute Physiology and Chronic Health EvaluationⅡスコアは予後の不良の要因であった.適切な抗真菌薬の選択と用法用量,治療期間は予後の改善する重要な項目である.一方,高齢,腎機能障害,肝機能障害,ステロイドを含む免疫抑制薬の使用などの患者背景もカンジダ血症の発生や予後不良のリスクとなることが知られており,コントロールが困難であることも多い.患者の栄養指標やリンパ球数も予後の予測因子となり,栄養状態の改善はカンジダ血症の予後向上のために行うべき対策である.この総説ではAFS活動とリスク要因となる患者の疾患背景をおもに取り上げ概説する.
Author 竹末, 芳生
中嶋, 一彦
一木, 薫
石川, かおり
山田, 久美子
植田, 貴史
Author_xml – sequence: 1
  fullname: 石川, かおり
  organization: 兵庫医科大学感染制御部
– sequence: 1
  fullname: 植田, 貴史
  organization: 兵庫医科大学感染制御部
– sequence: 1
  fullname: 一木, 薫
  organization: 兵庫医科大学感染制御部
– sequence: 1
  fullname: 竹末, 芳生
  organization: 常滑市民病院感染症科
– sequence: 1
  fullname: 山田, 久美子
  organization: 兵庫医科大学感染制御部
– sequence: 1
  fullname: 中嶋, 一彦
  organization: 兵庫医科大学感染制御部
BookMark eNo9kM1Kw0AUhQepYK3du_QFUjMzdxqzLKX-QEGQ7odJOtNOrbEkEXHXtAsFxaUiLvxZiFDoRsTiwpeZButbGFG7OfdwPjhwzzLKBYeBRGgV2yWMGYV1HbV1sK-DEiElG-MFlCdAwWKEOrm5J-4SKkaR9mwAhwFQN4_2KkGs1VHQEt21KJbHImxmVT2TjNPx3ezt1STPZjAywxczmJhhf_bQ_7w-zej0_Sz9uDDJ6OvqcTq5NMmNGZzPnpL09n4FLSrRjWTx7xZQY7PWqG5b9d2tnWqlbnWI7QpLMYY3pEcEBuZIx1fUo7LsKqmyhwhkSVk4TcWA2bZPPFCUORkBF4hs-oQWUO23thPFoiV5L9QHIjzhIoy135X8fxJephx-hBCeTTPnfluEvCPoNzxWdv4
ContentType Journal Article
Copyright 2022 一般社団法人日本医真菌学会
Copyright_xml – notice: 2022 一般社団法人日本医真菌学会
DOI 10.11534/ishinkin.22.011
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2434-5237
EndPage 98
ExternalDocumentID article_ishinkin_63_4_63_22_011_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
RJT
ID FETCH-LOGICAL-j209a-f5518eb2a1457e7cf3b3e69fef53424e7c6a7df54500c2b4f3575344942edc23
ISSN 2434-5229
IngestDate Wed Sep 03 06:30:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j209a-f5518eb2a1457e7cf3b3e69fef53424e7c6a7df54500c2b4f3575344942edc23
OpenAccessLink https://www.jstage.jst.go.jp/article/ishinkin/63/4/63_22.011/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_ishinkin_63_4_63_22_011_article_char_ja
PublicationCentury 2000
PublicationDate 2022/10/31
PublicationDateYYYYMMDD 2022-10-31
PublicationDate_xml – month: 10
  year: 2022
  text: 2022/10/31
  day: 31
PublicationDecade 2020
PublicationTitle 日本医真菌学会雑誌
PublicationTitleAlternate 真菌誌
PublicationYear 2022
Publisher 一般社団法人 日本医真菌学会
Publisher_xml – name: 一般社団法人 日本医真菌学会
References 6) Garbino J, Kolarova L, Rohner P, Lew D, Pichna P, Pittet D: Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 81: 425–433, 2002.
7) Choi HK, Jeong SJ, Lee HS, Chin BS, Choi SH, Han SH, Kim MS, Kim CO, Choi JY, Song YG, Kim JM: Blood stream infections by Candida glabrata and Candida krusei: a single-center experience. Korean J Intern Med 24: 263–269, 2009.
42) King EG, Bauzá GJ, Mella JR, Remick DG: Pathophysiologic mechanisms in septic shock. Lab Invest 94: 4–12, 2014.
47) Lee YC, Chen YC, Wang JT, Wang FD, Hsieh MH, Hii IM, Lee YL, Ho MW, Liu CE, Chen YH, Liu WL: Impact of nutritional assessment on the clinical outcomes of patients with non-albicans candidemia: a multicenter study. Nutrients 13: 3218, 2021.
14) Antworth A, Collins CD, Kunapuli A, Klein K, Carver P, Gandhi T, Washer L, Nagel JL: Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy 33: 137–143, 2013.
3) Sozio E, Pieralli F, Azzini AM, et al; GISA/FADOI Candida Study Group: A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study. Infection 46: 625–633, 2018.
5) Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, Wisplinghoff H, Vehreschild JJ: Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect 25: 1200–1212, 2019.
9) 二木芳人,賀来満夫,青木洋介,他:抗菌薬適正使用支援プログラム実践のためのガイダンス.日化療会誌 65: 650–687, 2017.
46) Kaito S, Sekiya N, Najima Y, et al: Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55: 661–664, 2020.
11) Takesue Y, Ueda T, Mikamo H, Oda S, Takakura S, Kitagawa Y, Kohno S; ACTIONs Project: Management bundles for candidaemia: the impact of compliance on clinical outcomes. J Antimicrob Chemother 70: 587–593, 2015.
1) Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J: Epidemiology and clinical features of invasive fungal infection in a US Health Care Network. Open Forum Infect Dis 5: ofy187, 2018.
17) Barchiesi F, Orsetti E, Mazzanti S, Trave F, Salvi A, Nitti C, Manso E: Candidemia in the elderly: what does it change? PLoS One 12: e0176576, 2017.
19) Alves PGV, Melo SGO, Bessa MAS, Brito MO, Menezes RP, Araújo LB, Penatti MPA, Pedroso RDS, Röder DVDB: Risk factors associated with mortality among patients who had candidemia in a university hospital. Rev Soc Bras Med Trop 53: e20190206, 2020.
20) Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI: Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20: O245–O254, 2014.
29) Jameran AS, Cheah SK, Tzar MN, Musthafa QA, Low HJ, Maaya M, Abdul Rahman R: An approach to develop clinical prediction rule for candidemia in critically ill patients: a retrospective observational study. J Crit Care 65: 216–220, 2021.
49) Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW: Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 39: 155–161, 2006.
33) van Asbeck EC, Hoepelman AI, Scharringa J, Verhoef J: The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. Int J Antimicrob Agents 33: 21–26, 2009.
39) Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF; OUTCOMEREA study group: Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive Care 7: 30, 2017.
36) Lee JY, Kim HI, Kim YN, Hong JH, Alshomimi S, An JY, Cheong JH, Hyung WJ, Noh SH, Kim CB: Clinical significance of the prognostic nutritional index for predicting short- and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients. Medicine (Baltimore) 95: e3539, 2016.
25) Hwang SY, Yu SJ, Lee JH, Kim JS, Yoon JW, Kim YJ, Yoon JH, Kim EC, Lee HS: Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis 33: 259–264, 2014.
43) Ortega-Loubon C, Cano-Hernández B, Poves-Alvarez R, Muñoz-Moreno MF, Román-García P, Balbás-Alvarez S, de la Varga-Martínez O, Gómez-Sánchez E, Gómez-Pesquera E, Lorenzo-López M, Tamayo E, Heredia-Rodríguez M: The overlooked immune state in candidemia: a risk factor for mortality. J Clin Med 8: 1512, 2019.
37) Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H: Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum 58: 1048–1057, 2015.
26) Bajaj JS, Reddy RK, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Fallon M, Maliakkal B, Lai J, Vargas HE, Subramanian RM, Thuluvath P, Thacker LR, OʼLeary JG: Prediction of fungal infection development and their impact on survival using the NACSELD cohort. Am J Gastroenterol 113: 556–563, 2018.
4) Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309–317, 2004.
13) Huang HY, Lu PL, Wang YL, Chen TC, Chang K, Lin SY: Usefulness of EQUAL Candida Score for predicting outcomes in patients with candidaemia: a retrospective cohort study. Clin Microbiol Infect 26: 1501–1506, 2020.
2) Soulountsi V, Schizodimos T, Kotoulas SC: Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible? Infection 49: 1107–1131, 2021.
21) Riche CVW, Cassol R, Pasqualotto AC: Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids? J Fungi (Basel) 6: 286, 2020.
22)Colombo AL, Guimarães T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, Nouér SA, Nucci M: Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 40: 1489–1498, 2014.
24) Hassan EA, Abd El-Rehim AS, Hassany SM, Ahmed AO, Elsherbiny NM, Mohammed MH: Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion. Int J Infect Dis 23: 69–74, 2014.
31) Mahajan S, Kalra OP, Asit KT, Ahuja G, Kalra V: Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Ren Fail 27: 357–360, 2005.
32) Scalas D, Banche G, Merlino C, Giacchino F, Allizond V, Garneri G, Patti R, Roana J, Mandras N, Tullio V, Cuffini AM: Role of caspofungin in restoring the impaired phagocyte-dependent innate immunity towards Candida albicans in chronic haemodialysis patients. Int J Antimicrob Agents 39: 73–76, 2012.
48) Hii IM, Chang HL, Lin LC, Lee YL, Liu YM, Liu CE, Chen CH, Cheng YR, Chang CY: Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect 48: 306-315, 2015.
30) Girndt M, Sester M, Sester U, Kaul H, Köhler H: Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78: S206–S211, 2001.
16) Luzzati R, Merelli M, Ansaldi F, Rosin C, Azzini A, Cavinato S, Brugnaro P, Vedovelli C, Cattelan A, Marina B, Gatti G, Concia E, Bassetti M: Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study. Infection 44: 747–755, 2016.
38) Hayıroğlu Mİ, Keskin M, Keskin T, Uzun AO, Altay S, Kaya A, Öz A, Çinier G, Güvenç TS, Kozan Ö: A novel independent survival predictor in pulmonary embolism: prognostic nutritional index. Clin Appl Thromb Hemost 24: 633–639, 2018.
44) Lew CCH, Yandell R, Fraser RJL, Chua AP, Chong MFF, Miller M: Association between malnutrition and clinical outcomes in the intensive care unit: a systematic review [formula: see text]. JPEN J Parenter Enteral Nutr 41: 744–758, 2017.
27) Bartoletti M, Rinaldi M, Pasquini Z, et al: Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study. Clin Microbiol Infect 27: 276–282, 2021.
10) 一般社団法人日本医真菌学会 侵襲性カンジダ症に対するマネジメントのための臨床実践ガイドライン作成委員会:侵襲性カンジダ症に対するマネジメントのための臨床実践ガイドライン.一般社団法人日本医真菌学会,東京,2021.
45) Piazza O, Boccia MC, Iasiello A, Storti MP, Tufano R, Triassi M: Candidemia in intensive care patients: risk factors and mortality. Minerva Anestesiol 70: 63–69, 2004.
8) Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159–177, 2007.
34) 小野寺時夫,五関謹秀,神前五郎:Stage IV・V(V は大腸癌)消化器癌の非治癒切除・姑息手術に対する TPN の適応と限界.日外会誌 85: 1001–1005, 1984.
35) Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF: Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139: 160–167, 1980.
40) Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS: Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42: 383–391, 2014.
41) Vulliamy PE, Perkins ZB, Brohi K, Manson J: Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients. Eur J Trauma Emerg Surg 42: 755–760, 2016.
28) Bassetti M, Peghin M, Carnelutti A, et al: Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med 43: 509–518, 2017.
15) Ghrenassia E, Mokart
References_xml – reference: 24) Hassan EA, Abd El-Rehim AS, Hassany SM, Ahmed AO, Elsherbiny NM, Mohammed MH: Fungal infection in patients with end-stage liver disease: low frequency or low index of suspicion. Int J Infect Dis 23: 69–74, 2014.
– reference: 25) Hwang SY, Yu SJ, Lee JH, Kim JS, Yoon JW, Kim YJ, Yoon JH, Kim EC, Lee HS: Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis. Eur J Clin Microbiol Infect Dis 33: 259–264, 2014.
– reference: 19) Alves PGV, Melo SGO, Bessa MAS, Brito MO, Menezes RP, Araújo LB, Penatti MPA, Pedroso RDS, Röder DVDB: Risk factors associated with mortality among patients who had candidemia in a university hospital. Rev Soc Bras Med Trop 53: e20190206, 2020.
– reference: 23) Guimarães T, Nucci M, Mendonça JS, Martinez R, Brito LR, Silva N, Moretti ML, Salomão R, Colombo AL: Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis 16: e442–e447, 2012.
– reference: 13) Huang HY, Lu PL, Wang YL, Chen TC, Chang K, Lin SY: Usefulness of EQUAL Candida Score for predicting outcomes in patients with candidaemia: a retrospective cohort study. Clin Microbiol Infect 26: 1501–1506, 2020.
– reference: 36) Lee JY, Kim HI, Kim YN, Hong JH, Alshomimi S, An JY, Cheong JH, Hyung WJ, Noh SH, Kim CB: Clinical significance of the prognostic nutritional index for predicting short- and long-term surgical outcomes after gastrectomy: a retrospective analysis of 7781 gastric cancer patients. Medicine (Baltimore) 95: e3539, 2016.
– reference: 35) Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF: Prognostic nutritional index in gastrointestinal surgery. Am J Surg 139: 160–167, 1980.
– reference: 11) Takesue Y, Ueda T, Mikamo H, Oda S, Takakura S, Kitagawa Y, Kohno S; ACTIONs Project: Management bundles for candidaemia: the impact of compliance on clinical outcomes. J Antimicrob Chemother 70: 587–593, 2015.
– reference: 12) Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Flörl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA: EQUAL Candida Score: an ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management. Mycoses 61: 326–330, 2018.
– reference: 32) Scalas D, Banche G, Merlino C, Giacchino F, Allizond V, Garneri G, Patti R, Roana J, Mandras N, Tullio V, Cuffini AM: Role of caspofungin in restoring the impaired phagocyte-dependent innate immunity towards Candida albicans in chronic haemodialysis patients. Int J Antimicrob Agents 39: 73–76, 2012.
– reference: 6) Garbino J, Kolarova L, Rohner P, Lew D, Pichna P, Pittet D: Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital. Medicine (Baltimore) 81: 425–433, 2002.
– reference: 38) Hayıroğlu Mİ, Keskin M, Keskin T, Uzun AO, Altay S, Kaya A, Öz A, Çinier G, Güvenç TS, Kozan Ö: A novel independent survival predictor in pulmonary embolism: prognostic nutritional index. Clin Appl Thromb Hemost 24: 633–639, 2018.
– reference: 46) Kaito S, Sekiya N, Najima Y, et al: Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 55: 661–664, 2020.
– reference: 39) Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF; OUTCOMEREA study group: Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission. Ann Intensive Care 7: 30, 2017.
– reference: 9) 二木芳人,賀来満夫,青木洋介,他:抗菌薬適正使用支援プログラム実践のためのガイダンス.日化療会誌 65: 650–687, 2017.
– reference: 33) van Asbeck EC, Hoepelman AI, Scharringa J, Verhoef J: The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis. Int J Antimicrob Agents 33: 21–26, 2009.
– reference: 37) Tokunaga R, Sakamoto Y, Nakagawa S, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Baba H: Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum 58: 1048–1057, 2015.
– reference: 31) Mahajan S, Kalra OP, Asit KT, Ahuja G, Kalra V: Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Ren Fail 27: 357–360, 2005.
– reference: 4) Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39: 309–317, 2004.
– reference: 49) Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW: Risk factors for candidemia-related mortality at a medical center in central Taiwan. J Microbiol Immunol Infect 39: 155–161, 2006.
– reference: 7) Choi HK, Jeong SJ, Lee HS, Chin BS, Choi SH, Han SH, Kim MS, Kim CO, Choi JY, Song YG, Kim JM: Blood stream infections by Candida glabrata and Candida krusei: a single-center experience. Korean J Intern Med 24: 263–269, 2009.
– reference: 8) Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44: 159–177, 2007.
– reference: 22)Colombo AL, Guimarães T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, Nouér SA, Nucci M: Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period. Intensive Care Med 40: 1489–1498, 2014.
– reference: 26) Bajaj JS, Reddy RK, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Fallon M, Maliakkal B, Lai J, Vargas HE, Subramanian RM, Thuluvath P, Thacker LR, OʼLeary JG: Prediction of fungal infection development and their impact on survival using the NACSELD cohort. Am J Gastroenterol 113: 556–563, 2018.
– reference: 43) Ortega-Loubon C, Cano-Hernández B, Poves-Alvarez R, Muñoz-Moreno MF, Román-García P, Balbás-Alvarez S, de la Varga-Martínez O, Gómez-Sánchez E, Gómez-Pesquera E, Lorenzo-López M, Tamayo E, Heredia-Rodríguez M: The overlooked immune state in candidemia: a risk factor for mortality. J Clin Med 8: 1512, 2019.
– reference: 2) Soulountsi V, Schizodimos T, Kotoulas SC: Deciphering the epidemiology of invasive candidiasis in the intensive care unit: is it possible? Infection 49: 1107–1131, 2021.
– reference: 15) Ghrenassia E, Mokart D, Mayaux J, Demoule A, Rezine I, Kerhuel L, Calvet L, De Jong A, Azoulay E, Darmon M: Candidemia in critically ill immunocompromised patients: report of a retrospective multicenter cohort study. Ann Intensive Care 9: 62, 2019.
– reference: 27) Bartoletti M, Rinaldi M, Pasquini Z, et al: Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case-control-control study. Clin Microbiol Infect 27: 276–282, 2021.
– reference: 16) Luzzati R, Merelli M, Ansaldi F, Rosin C, Azzini A, Cavinato S, Brugnaro P, Vedovelli C, Cattelan A, Marina B, Gatti G, Concia E, Bassetti M: Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study. Infection 44: 747–755, 2016.
– reference: 48) Hii IM, Chang HL, Lin LC, Lee YL, Liu YM, Liu CE, Chen CH, Cheng YR, Chang CY: Changing epidemiology of candidemia in a medical center in middle Taiwan. J Microbiol Immunol Infect 48: 306-315, 2015.
– reference: 21) Riche CVW, Cassol R, Pasqualotto AC: Is the frequency of candidemia increasing in COVID-19 patients receiving corticosteroids? J Fungi (Basel) 6: 286, 2020.
– reference: 34) 小野寺時夫,五関謹秀,神前五郎:Stage IV・V(V は大腸癌)消化器癌の非治癒切除・姑息手術に対する TPN の適応と限界.日外会誌 85: 1001–1005, 1984.
– reference: 14) Antworth A, Collins CD, Kunapuli A, Klein K, Carver P, Gandhi T, Washer L, Nagel JL: Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy 33: 137–143, 2013.
– reference: 30) Girndt M, Sester M, Sester U, Kaul H, Köhler H: Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 78: S206–S211, 2001.
– reference: 45) Piazza O, Boccia MC, Iasiello A, Storti MP, Tufano R, Triassi M: Candidemia in intensive care patients: risk factors and mortality. Minerva Anestesiol 70: 63–69, 2004.
– reference: 44) Lew CCH, Yandell R, Fraser RJL, Chua AP, Chong MFF, Miller M: Association between malnutrition and clinical outcomes in the intensive care unit: a systematic review [formula: see text]. JPEN J Parenter Enteral Nutr 41: 744–758, 2017.
– reference: 47) Lee YC, Chen YC, Wang JT, Wang FD, Hsieh MH, Hii IM, Lee YL, Ho MW, Liu CE, Chen YH, Liu WL: Impact of nutritional assessment on the clinical outcomes of patients with non-albicans candidemia: a multicenter study. Nutrients 13: 3218, 2021.
– reference: 42) King EG, Bauzá GJ, Mella JR, Remick DG: Pathophysiologic mechanisms in septic shock. Lab Invest 94: 4–12, 2014.
– reference: 10) 一般社団法人日本医真菌学会 侵襲性カンジダ症に対するマネジメントのための臨床実践ガイドライン作成委員会:侵襲性カンジダ症に対するマネジメントのための臨床実践ガイドライン.一般社団法人日本医真菌学会,東京,2021.
– reference: 20) Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B; CANDIPOP Project; GEIH-GEMICOMED (SEIMC); REIPI: Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 20: O245–O254, 2014.
– reference: 17) Barchiesi F, Orsetti E, Mazzanti S, Trave F, Salvi A, Nitti C, Manso E: Candidemia in the elderly: what does it change? PLoS One 12: e0176576, 2017.
– reference: 40) Drewry AM, Samra N, Skrupky LP, Fuller BM, Compton SM, Hotchkiss RS: Persistent lymphopenia after diagnosis of sepsis predicts mortality. Shock 42: 383–391, 2014.
– reference: 3) Sozio E, Pieralli F, Azzini AM, et al; GISA/FADOI Candida Study Group: A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study. Infection 46: 625–633, 2018.
– reference: 5) Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, Wisplinghoff H, Vehreschild JJ: Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect 25: 1200–1212, 2019.
– reference: 28) Bassetti M, Peghin M, Carnelutti A, et al: Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study. Intensive Care Med 43: 509–518, 2017.
– reference: 1) Webb BJ, Ferraro JP, Rea S, Kaufusi S, Goodman BE, Spalding J: Epidemiology and clinical features of invasive fungal infection in a US Health Care Network. Open Forum Infect Dis 5: ofy187, 2018.
– reference: 41) Vulliamy PE, Perkins ZB, Brohi K, Manson J: Persistent lymphopenia is an independent predictor of mortality in critically ill emergency general surgical patients. Eur J Trauma Emerg Surg 42: 755–760, 2016.
– reference: 18) Jia X, Li C, Cao J, Wu X, Zhang L: Clinical characteristics and predictors of mortality in patients with candidemia: a six-year retrospective study. Eur J Clin Microbiol Infect Dis 37: 1717–1724, 2018.
– reference: 29) Jameran AS, Cheah SK, Tzar MN, Musthafa QA, Low HJ, Maaya M, Abdul Rahman R: An approach to develop clinical prediction rule for candidemia in critically ill patients: a retrospective observational study. J Crit Care 65: 216–220, 2021.
SSID ssib044754439
ssib035296382
ssj0003315349
Score 1.8923557
Snippet カンジダ血症は入院患者の主要な侵襲性真菌感染症であり,高い死亡率をもたらす.Antifungal...
SourceID jstage
SourceType Publisher
StartPage 93
SubjectTerms Antifungal stewardship
カンジダ血症
バンドル
リスク
Title Antifungal stewardshipの実践とカンジダ血症の予後に関与する要因
URI https://www.jstage.jst.go.jp/article/ishinkin/63/4/63_22.011/_article/-char/ja
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本医真菌学会雑誌, 2022/10/31, Vol.63(4), pp.93-98
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1NaxQxdCj14kUqKn7TgznJ1NkkM5NchGQ7SxHqQSr0NszMzkBXqFK2Fw_SbQ8KikdFPPhxEKHQi4jFg39mWqz_wvcySWf8OFh7CeEleZ8b3nvZl4znXWO9IuKF5H4si8rnWZj5WRFSP4-kGFYZpXmF_-gu3o4W7vJby-Hy1PRMp2ppfZzPFQ__eq_kf6wKMLAr3pI9gmUPkQIA-mBfaMHC0P6TjRVW-sBuNXc-Sqx_xdorkjCID4lKSBJiKwckEUTHRIduSJgOJUqbDiOaWYgWFiICXKV6phMTGRMRdzBzohURAknohIi-GwKEksiIKGrmCCISOySlJSG0wRwhEJZLTVTQjZFJEiE5FZpOn6g-TgMSWhtO-lYiMTB0QcZ5xIbkYEgZBjSRPUMFmDw8BzarB0bWEPUh5_EHZtkT2nWU41O1C0EgCLrnDQagEzQLQaugMW7YA7y0nd-IHjgJhJuPmtFdfkBhWrpp2k0DHpBLQ0wOuiczkNS3Lg33UoeWQIOgtmLkVidOuwzxAz4ZWrtpdf2YSm79B-WM-xBeNx6p7MKad3acA7QeZqV7umO8WfPtShsXNR8L_9PjhozDPjEHpvdWVuconQus-_z1HXO7S1I3M41YyrGhNIUVqRvH24bpCFKeEzSOTeXF4qPEuQiGZQKsfY4Jn6vk3D5si8EXY8gQJr2H4rviBIDf-I1NCDtHkIS5Ak4TUy7NeKdsMjirGp5Oe1Oj7Ix3p93Vs51dXU929nfeHHz5XE8-1pvb9danenO33to4eLfx_eVjGN37-mT_27N6sv3jxfu93ef15FW9-fTgw2T_9duz3tIgWeov-PbLJ_6IBjLzK3wnscxp1uNhXMZFxXJWRrIqKxCCcoBEWTysIPsJgoLmvGKQdTHOJaflsKDsnDe9en-1PO_NhhmV4KKLSEjKqx7euRkyPOMYyiEVBbvg3Ww0kD5oXrdJj2ini8dFcMk72W6ey970eG29vAKB_ji_akz_Ex_lz8c
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antifungal+stewardship%E3%81%AE%E5%AE%9F%E8%B7%B5%E3%81%A8%E3%82%AB%E3%83%B3%E3%82%B8%E3%83%80%E8%A1%80%E7%97%87%E3%81%AE%E4%BA%88%E5%BE%8C%E3%81%AB%E9%96%A2%E4%B8%8E%E3%81%99%E3%82%8B%E8%A6%81%E5%9B%A0&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%8C%BB%E7%9C%9F%E8%8F%8C%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E7%9F%B3%E5%B7%9D%2C+%E3%81%8B%E3%81%8A%E3%82%8A&rft.au=%E6%A4%8D%E7%94%B0%2C+%E8%B2%B4%E5%8F%B2&rft.au=%E4%B8%80%E6%9C%A8%2C+%E8%96%AB&rft.au=%E7%AB%B9%E6%9C%AB%2C+%E8%8A%B3%E7%94%9F&rft.date=2022-10-31&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8C%BB%E7%9C%9F%E8%8F%8C%E5%AD%A6%E4%BC%9A&rft.issn=2434-5229&rft.eissn=2434-5237&rft.volume=63&rft.issue=4&rft.spage=93&rft.epage=98&rft_id=info:doi/10.11534%2Fishinkin.22.011&rft.externalDocID=article_ishinkin_63_4_63_22_011_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2434-5229&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2434-5229&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2434-5229&client=summon